MAY 29TH 2019, 06:00AM

EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today reported the Company’s consolidated interim financial results for the second quarter ended March 31, 2019.

EnWave’s interim consolidated financial statements and MD&A are available on SEDAR at www.sedar.com and on the Company’s website www.enwave.net.

Key Financial Highlights for Q2 (expressed in ‘000s):

• Reported record quarterly revenue for the Company in Q2 2019 of $8,773, an increase of $4,601 when compared to $4,172 for Q2 of 2018. Revenue growth was driven by increased sales and distribution of the Company’s Moon Cheese^® product as well as an increase in REV™ equipment sales into the cannabis sector.
• More than doubled gross profit, improving to $3,120 for Q2 2019 compared to $1,295 for Q2 2018, an increase of $1,825 or 141%. Gross margin as a percentage of revenue was 36% for Q2 2019 compared to 31% for Q2 2018.
• Increased cash profitability with Adjusted EBITDA^(*) of $1,002 for Q2 2019 compared to $4 for Q2 2018, an increase of $998. Q2 YTD Adjusted EBITDA^(*) for the Company was $2,165, compared to $319 for Q2 YTD 2018. The growth in positive EBITDA represents the Company’s continued ability to generate cash from its operations.

• Reduced the consolidated net loss for the period after taxes to $224 for Q2 2019 compared to a net loss of $519 for Q2 2018, an improvement of $295. With sales of Moon Cheese^® and REV™ equipment increasing the Company is making robust progress towards consolidated profitability.
• Increased G&A expenses to $1,049 for Q2 2019 compared to $606 for Q2 2018, an increase of $443. The Company added several talented new personnel to the team, including a new CEO for NutraDried, as well as invested in a scalable infrastructure to facilitate growth in machine sales and Moon Cheese^®.
• Invested in top-line growth with S&M expenses of $1,084 for Q2 2019 compared to $683 for Q2 2018, an increase of $401. S&M expenses increased as part of the Company’s strategy to invest in the Moon Cheese^® brand as well as more traditional selling activity to promote REV™ technology across the food and cannabis sectors.
• Reported cash on the balance sheet of $12,200 at the end of the second quarter and subsequently completed a strategic investment with Aurora Cannabis Inc. (“Aurora”) in the Company for gross proceeds of $10,087. The Company is positioned with a debt-free balance sheet and cash in excess of $20 million paired with a positive cash flow profile.

Significant Accomplishments:

• Signed a royalty-bearing commercial sub-license agreement with Aurora granting Aurora non-exclusive rights to use EnWave’s technology for processing cannabis in Canada. Aurora purchased two 120kW REV™ machines and a 10kW machine for installation in Canada.
• Entered into a royalty-bearing commercial license agreement with Aurora granting Aurora exclusive rights, with the rights to grant sub-licenses, for processing cannabis in the European Union (excluding Portugal). Aurora must purchase a 120kW REV™ machine for installation in the European Union before June 25, 2019 to retain the exclusive rights.
• Partnered with Aurora to develop new innovations and intellectual property related to REV™ and its applications in the cannabis sector by signing an intellectual property agreement and initiating new joint development projects.
• Entered into a royalty-bearing commercial sub-license agreement with The Green Organic Dutchman (“TGOD”) granting TGOD non-exclusive rights to use EnWave’s technology for processing legalized cannabis in Canada. TGOD purchased four large-scale REV™ machines for installation in Canada including a 60kW REV™ machine and three 120kW REV™ machines, all with automated robotic tray handling systems.
• Shipped the first 60kW machine to Tilray Inc. (“Tilray”) and began the installation and commissioning processes on the first large-scale continuous cannabis processing line.
• Signed a royalty-bearing commercial license agreement with Calbee Inc. (“Calbee”) and received a purchase order for a 10kW machine. Calbee, a major Japanese snacking company, plans to conduct intense product development in 2019 and to launch several new products through market testing efforts in 2020.
• Converted Fresh Business Consulting S.L. (“Fresh Business) from a technology evaluation agreement into a royalty-bearing commercial license agreement and granted Fresh Business exclusive rights to produce a variety of premium food products in Peru. Fresh Business initially purchased a 10kW machine and must commit to purchasing a 100kW or larger machine before July 31, 2019 to retain exclusivity in Peru.
• Advanced the development of nutrient rich field rations with the U.S. Army and announced the purchase of a second small-scale REV™ machine by the U.S. Army as part of the ongoing project. The Company is collaborating with the U.S. Army and its approved supplier network as part of the strategy to commercialize REV™ for high quality field rations with superior taste and nutrients.
• Signed a royalty-bearing commercial license agreement with Royal FrieslandCampina N.V. (“Friesland Campina”), one of Europe’s largest dairy companies. Friesland Campina will deploy REV™ technology to develop new products that fit evolving consumer needs and taste preferences. Friesland Campina purchased a 10kW REV™ unit to initiate production.
• Selected as a 2019 Venture 50™ company in the Clean Technology & Life Sciences category.
• Appointed Mr. Stephen Sanford as a new independent member on the Company’s Board of Directors. Mr. Sanford is Managing General Counsel at Fluor Corporation and has significant experience structuring major commercial transactions in a variety of legal frameworks on a global basis.
• Continued to expand the sales and distribution of Moon Cheese^® throughout the United States in the club and retail grocery channels. NutraDried hired Mr. Joe Spinazola as the new Senior Vice President of Sales in April 2019 to further advance this effort and Mr. Spinazola will work closely with NutraDried’s CEO to grow distribution of its all-natural snack product, Moon Cheese^®, and to launch new products and flavours.

Investor Relations Agreement:

The Company retained Mr. Jochen Staiger of Swiss Resource Capital (“SRC”) to provide investor relations services for the Company in the European capital markets.  SRC will broaden awareness of EnWave’s investment case in Europe with retail and institutional investors. SRC will be remunerated CHF 5,000 per month (CAD $6,650) for the twelve-month term of the contract starting on June 1, 2019. The Company previously announced on September 11, 2018 that 50,000 incentive stock options were granted to Mr. Staiger; no additional incentive stock options have been granted as part of SRC’s compensation.

^(*) Non-IFRS Financial Measures:

Adjusted EBITDA is not a measure of financial performance under IFRS. We define Adjusted EBITDA as earnings before deducting amortization and depreciation, stock based compensation, foreign exchange gain or loss, finance expense or income, income tax expense and non-recurring impairment charges. This measure is not necessarily comparable to similarly titled measures used by other companies and should not be construed as an alternative to net income or cash flow from operating activities as determined in accordance with IFRS. Please refer to the discussion included in the Company’s interim MD&A for March 31, 2019 and annual MD&A for the year ended September 30, 2018.

エンウェーブについて

バンクーバーを拠点とする先端技術企業、エンウェーブ・コーポレーションは、有機材料を精密に脱水する革新的な独自手法であるラジアント・エナジー・バキューム（REV™）を開発した。REV™技術の商業的可能性は実証済みで、食品、合法大麻、製薬の各分野で急速に成長しています。エンウェーブの戦略は、REV™技術の使用に関して、複数の垂直市場における業界大手とロイヤリティを伴う商業ライセンスを締結することです。同社は現在までに20以上のロイヤリティ付きライセンスを締結しており、革新的な新製品の商業化に向けて8つの市場分野を開拓している。これらのライセンスに加え、エンウェーブはNutraDried LLPという有限責任事業組合を設立し、米国でMoon Cheese®ブランドのナチュラルチーズスナック製品の開発、製造、マーケティング、販売を行っています。

エンウェーブは、凍結乾燥よりも迅速かつ低コストで、風乾や噴霧乾燥よりも優れた最終製品品質を実現するREV™を、食品および生物材料の分野における新たな脱水標準として導入しました。
1.nutraREV®は、食品産業において、栄養、味、食感、色を高いレベルで維持しながら、食品を迅速かつ低コストで乾燥させるために使用されています。
2.powderREV®は、食品培養物、プロバイオティクス、酵素などのファインバイオケミカルを凝固点以下でバルク脱水するために使用されています。
3. quantaREV®は、連続的な大量低温乾燥に使用される。
追加のプラットフォームであるfreezeREV®は、ワクチンや抗体などのバイオ医薬品を安定化・脱水する新しい方法として開発中である。エンウェーブ社に関する詳細は、www.enwave.net。

エンウェーブ社
ティム・デュランス博士
社長兼CEO

お問い合わせ：
ジョン・バドレスキー（エグゼクティブ・チェアマン） 電話：+1 (416) 930-0914
E-mail:jbudreski@enwave.net

ブレント・チャールトン、営業・事業開発担当シニア・バイス・プレジデント、電話：+1 (778) 378-9616
E-mail:bcharleton@enwave.net

Deborah Honig, Corporate Development, Adelaide Capital Markets 電話：+1 (647) 203-8793
E-mail:dhonig@enwave.net

将来予測情報に関する記述のセーフハーバー：本プレスリリースには、経営陣の期待、見積もり、予測に基づく将来の見通しに関する情報が含まれている場合があります。当社の成長戦略、製品開発、市場での地位、予想される支出、クロージング後に期待されるシナジー効果に関する記述を含め、将来に対する期待や予測に言及する記述はすべて、将来の見通しに関する記述です。本リリースで言及されている第三者の主張はすべて、その正確性を保証するものではありません。本リリースに記載されている市場情報に関する第三者の言及はすべて、当社が独自に一次調査を行ったものではないため、正確性を保証するものではありません。これらの記述は将来の業績を保証するものではなく、多くのリスク、不確実性および仮定を含んでいます。当社は、実際の結果と大きく異なる可能性のある重要な要因を特定するよう努めましたが、予想、見積りまたは意図したとおりの結果とならないその他の要因が存在する可能性があります。実際の結果や将来の事象は、かかる記述で予想されたものとは大きく異なる可能性があるため、かかる記述が正確であることを保証するものではありません。したがって、読者は将来の見通しに関する記述を過度に信頼すべきではありません。

TSXベンチャー取引所およびその規制サービスプロバイダー（この用語はTSXベンチャー取引所の方針で定義されています）は、本リリースの妥当性または正確性について責任を負いません。